Database

Startups

Main Industry
Biotechnology
Main Product/Service
Their key offerings include allogenic mesenchymal stem cell therapy (UMSC01) and dendritic cell-based cancer vaccines (ADCV01), designed for applications in heart attack, stroke, and cancer treatment.
Founded Year
2016
Unified Business No.
60274720
Status
Active
Number of Employees
0
Total Paid-in Capital
875,969,630 (NT$)
Location of Company
Taiwan , Taichung City
Exit Status
OTC listing(2021)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
Ever Supreme Bio Technology Co., Ltd. is a Taiwanese biotech company dedicated to developing cell and gene therapy. Its mission is to advance human health and quality of life through innovative biotherapeutics.



More ↓

Similar Companies

AMARAN BIOTECHNOLOGY, INC.

1. Adjuvants
2. Drug Substance Manufacturing
3. Drug Product Manufacturing
4. Stability Study & Analytical Science Services
5. Sourcing & Consultation Services

EIRGENIX, INC.

1. Trastuzumab Biosimilar
2. CDMO Services
3. CRM197 Carrier Protein
4. COVID-19 Antigen Rapid Test

FORESEE PHARMACEUTICALS CO., LTD.

1. CAMCEVI 42 mg
2. CAMCEVI 21 mg
3. FP-025
4. FP-045
5. Aderamastat (FP-025) Phase 2 Study

Genovior Biotech Corporation

1. process development of peptide or protein APIs from microbial or human recombinant fermentation processes
2. formulation development of biological injectable
3. manufacturing capacities of biological APIs, lyophilized injectable, and prefilled syringe/